Also trades as: PRENW (NASDAQ) · $vol 0M
PRE NASDAQ
Prenetics Global Limited
1W: -1.1%
1M: -19.0%
3M: +2.3%
YTD: +16.8%
1Y: +10.0%
3Y: +186.2%
5Y: -84.0%
$18.43
+0.06 (+0.33%)
Weekly Expected Move ±10.6%
$14
$16
$17
$19
$21
Credit Risk of going bust: lower than 67% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.01 (down 99.9%), Prenetics Global Limited would be worth roughly what it owes.
Total debt $682K against a stock market value of $312.2M.
Distance to default 7.12 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $538K (short-term plus half of long-term), stock volatility 85.0%; Altman Z'' 3.44. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $682K against a stock market value of $312.2M.
Distance to default 7.12 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $538K (short-term plus half of long-term), stock volatility 85.0%; Altman Z'' 3.44. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider+$1.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$312.2M
52W Range11.365-27.24
Volume249,506
Avg Volume213,233
Beta0.25
Dividend—
Analyst Ratings
Company Info
CEOSheng Wu Yeung
Employees98
SectorConsumer Defensive
IndustryHousehold & Personal Products
IPO Date2021-07-16
Websiteprenetics.com
Unit 701-706, K11 Atelier Kingâs Road
Hong Kong
HK
Hong Kong
HK
852 2210 9588
About Prenetics Global Limited
Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform. The company's main brand is IM8, which offers science-backed nutritional supplements. It also operates CircleDNA, a consumer genetic testing brand that provides personalized health reports based on sequencing technology.
Latest News
Prenetics (PRE) Q2 2026 Earnings Call Transcript
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
Here are the major earnings before the open Tuesay
Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue
Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Leogrande Hudson Bla | M-Exempt | 2,000 | — | 2026-10-04 |
| Leogrande Hudson Bla | M-Exempt | 2,000 | — | 2026-10-04 |
| Lo Hoi Chun | M-Exempt | 7,635 | — | 2026-09-30 |
| Lo Hoi Chun | M-Exempt | 7,635 | — | 2026-09-30 |
| Leogrande Hudson Bla | M-Exempt | 2,000 | — | 2026-09-04 |